HSV

HSV-1/HSV-2-IN-3 is a potent inhibitor of the herpes simplex virus (HSV) helicase-primase complex, effectively disrupting the DNA unwinding and primer synthesis necessary for viral genome replication. It demonstrates an EC50 of 7.0 nM against HSV-2 in gD-immunofluorescence assays, and 1.1 nM in qPCR replication assays, highlighting its potent antiviral activity. Additionally, HSV-1/HSV-2-IN-3 exhibits high selectivity for viral targets, with an IC50 of approximately 2.9 µM for human carbonic anhydrase II, making it a valuable tool for anti-HSV research applications.

(S)-HN0037 is a selective helicase-primase inhibitor that effectively targets the viral helicase-primase complex, thereby inhibiting herpes simplex virus (HSV) replication. Its oral bioactivity makes it a valuable tool for studying HSV pathology and developing antiviral therapies. Researchers can utilize (S)-HN0037 in various experimental models to investigate mechanisms of viral replication and explore potential therapeutic interventions against HSV infections.

C-AFG is a novel herpes simplex virus (HSV) inhibitor that demonstrates potent activity against both HSV-1 and HSV-2. This compound exhibits high selectivity, making it a valuable tool for research on viral infections and the mechanisms of antiviral action. C-AFG is suitable for studies focusing on therapeutic strategies against herpesvirus-related diseases.

HSV-1-IN-3 is a potent inhibitor of herpes simplex virus (HSV) with demonstrated antiviral activity against both Acyclovir-sensitive and -resistant HSV strains. This compound has potential applications in virology research, particularly in studies focused on understanding and developing treatments for HSV infections. Its effectiveness against resistant strains makes it a valuable tool in the search for new antiviral therapies.

Woodorien is a potent inhibitor of herpes simplex virus type 1 (HSV-1), demonstrating strong antiviral activity. Isolated from the plant Woodwardia orientalis, Woodorien functions as a glucoside that impacts viral replication. This compound serves as a valuable tool for studying HSV-1 infection mechanisms and the development of antiviral therapies.

Rociclovir is an acyclic nucleoside derivative that functions as an inhibitor of herpes simplex virus (HSV) and murine cytomegalovirus (MCMV). It has demonstrated protective effects in murine models against HSV and MCMV infections. However, it is important to note that Rociclovir exhibits limited antiviral activity in cell culture systems, highlighting its primary utility in in vivo research applications.

Cycloviracin B1 is a potent inhibitor of herpes simplex virus type 1 (HSV-1), demonstrating significant antiviral activity against this pathogen. In addition to its primary application in virology, it exhibits weak anti-Gram-positive bacterial activity, which may provide further avenues for research. This compound is valuable for studies focused on HSV-1 infection and potential therapeutic interventions.

Arabinosylhypoxanthine is a purine nucleoside analog that selectively inhibits viral DNA synthesis. It demonstrates significant anti-herpes simplex virus (HSV) activity, making it a valuable tool for research on herpes simplex virus infections. This compound can be utilized to investigate mechanisms of antiviral action and to develop therapeutic strategies against HSV.

Adipic acid (Hexanedioic acid) primarily functions as an anti-HSV agent, exhibiting effective antiviral activity against HSV-1. This compound is characterized by its low toxicity, making it suitable for applications as a food additive and gelling agent. Additionally, adipic acid serves as an important intermediate in the synthesis of lubricants, artificial resins, and plastics, highlighting its versatility in chemical research and industrial applications.